SHENZHEN LAIXI TECHNOLOGY CO.,LTD. – Trademark Portfolio

Entity Type: 99

SHENZHEN LAIXI TECHNOLOGY CO.,LTD. holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include HWALLKARE. The owner is based in SHENZHEN, GUANGDONG PROVINCE.

ROOM 708, BUILDING F-1, JINYU LINGFENG GARDEN, NO. 155 BULONG ROAD, SHUIJING COMMUNITY, JIHUA STREET, LONGGANG DISTRICT,

SHENZHEN, GUANGDONG PROVINCE 518000 , CN

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

HWALLKARE
HWALLKARE
Registered 2020

Trademark Classifications

SHENZHEN LAIXI TECHNOLOGY CO.,LTD.'s trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does SHENZHEN LAIXI TECHNOLOGY CO.,LTD. have?

SHENZHEN LAIXI TECHNOLOGY CO.,LTD. has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does SHENZHEN LAIXI TECHNOLOGY CO.,LTD. file in?

SHENZHEN LAIXI TECHNOLOGY CO.,LTD. files trademarks across 1 Nice Classification class. The most active classes are Class 10 (Medical Apparatus). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.

What are SHENZHEN LAIXI TECHNOLOGY CO.,LTD.'s most well-known trademarks?

SHENZHEN LAIXI TECHNOLOGY CO.,LTD.'s registered trademark portfolio includes well-known marks such as HWALLKARE. These are among 1 currently registered trademark in the portfolio.

What is SHENZHEN LAIXI TECHNOLOGY CO.,LTD.'s trademark registration success rate?

SHENZHEN LAIXI TECHNOLOGY CO.,LTD. has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.